The Institute for OneWorld Health, the US-based non-profit pharmaceutical company, has appointed Robert Farrell, JD as its chief financial officer (CFO).
Prior to joining OneWorld Health, Farrell served as president and CFO of Titan Pharmaceuticals, a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cardiovascular disease and bone disease. He also served as Titan’s executive vice president and CFO from 1996 to 2008.
Previously, Farrell held senior positions at dialysis services provider Fresenius USA from 1991 until August 1996, where he served as corporate group vice president, vice president administration, CFO and general counsel.
Farrell has also served as vice president, marketing and president of TXL Securities at Genstar Corporation, as associate general counsel at Brae Corporation, and as an associate attorney at Crane & Hawkins.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.